Originally posted by the Voice of America.
Voice of America content is produced by the Voice of America,
a United States federal government-sponsored entity, and is in
the public domain.


China Conditionally OKs Public Use of 2nd COVID-19 Vaccine

VOA News

   China has conditionally approved a second COVID-19 vaccine for public
   use.

   The National Medical Products Administration said in a statement
   Saturday that regulators approved the use of Sinovac Biotech Ltd.'s
   CoronaVac the day before.

   A vaccine developed by a Chinese institute affiliated with the
   state-owned China National Pharmaceutical Group (Sinopharm) was
   approved for public use two months ago.

   The Sinovac vaccine, which is being administered in at least five other
   countries, was given emergency approval last July for people at high
   risk for infection, such as health care workers and employees of
   state-owned companies.

   Conditional approval of the vaccine allows its use for the general
   public while research continues. The company must submit current data
   and reports of any adverse effects after the vaccine is sold on the
   market.

   A third candidate vaccine from Sinopharm has already been administered
   to high-risk groups in China, while a fourth candidate from CanSino
   Biologics is being administered to military personnel.

.